Cancer pathology and pregnancy: evidence, experience, capabilities
DOI:
https://doi.org/10.18370/2309-4117.2014.20.89-92Keywords:
oncopathology, pregnancy, progesterone, UtrozhestanAbstract
October 29th of this year the conference «Oncopathology and Reproduction – Opportunities and Prospects» took place in Kiev. Y.V. Davydova report that is presented in this paper was devoted to the fight against cancer and save pregnancy at the same time.
The main goal of treatment of diagnosed cancer in pregnancy is a disease control and prevention of distant metastasis, as well as full protection of the developing fetus.
In this case, if a woman is going to save her pregnancy it should treat threatening miscarriage by drugs with maximum efficiency and minimum range of side effects for the mother and the fetus. The vaginal form of progesterone (preparation Utrozhestan) is the most commonly used is among such drugs
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2015 Ю. В. Давыдова
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
